Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Adenocarcinoma pancreas
ADR ID BADD_A05179
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.10      Pancreatic neoplasms malignant (excl islet cell and carcinoid)
16.13.10.002      Adenocarcinoma pancreas
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.09      Pancreatic neoplasms
07.21.09.003      Adenocarcinoma pancreas
Description Not Available
MedDRA Code 10052747
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Pancreatic adenocarcinoma non-resectable | Pancreatic adenocarcinoma resectable | Pancreatic adenocarcinoma | Adenocarcinoma pancreas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00036Acitretin--
BADD_D00230Bendamustine0.000112%
BADD_D00349Capecitabine0.000280%
BADD_D00567Dabrafenib mesylate--
BADD_D00680Dimethyl fumarate0.000400%
BADD_D01009Gemcitabine0.000112%
BADD_D01253Lenalidomide0.000603%
BADD_D01401Metformin0.000005%
BADD_D01653Paclitaxel0.000224%
BADD_D01913Ranitidine0.000038%
BADD_D02029Sitagliptin0.001061%
BADD_D02165Teriflunomide0.000241%
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages